The Doris Duke Innovations in Clinical Research Award has provided funding for early-stage research projects in clinical investigation to foster innovations in clinical research that advance the prevention, diagnosis and treatment of human disease.
Rationale & Program History
The Medical Research Program created the Innovations in Clinical Research Award (ICRA) to catalyze breakthroughs in targeted disease areas. The program has supported 82 awards totaling approximately $25.7 million for innovative clinical research in cardiovascular disease, stroke, blood disorders, sickle cell disease and the development of diagnostics and therapeutic monitoring of AIDS in resource-poor countries.
Beginning in 2009, the Innovations in Clinical Research Award provided three-year grants of $486,000 each to investigators conducting clinical research that had the potential to accelerate innovative breakthroughs in sickle cell disease. While the ICRA program is not currently offering new grants, several previously funded projects are ongoing. View the 2009-2015 grantees here.
To receive announcements about future competitions for this and other programs, subscribe to our listserv here.